ST. PETERSBURG, FL, Dec. 16, 2014 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTCQB; FWDG), a leading provider of advanced
technologies and solutions to the global cannabis industry,
announced that CB Scientific, a subsidiary of FutureWorld Corp.,
has received the "Product of the Year" from the Cannabis Business
Awards. The Cannabis Business Awards are presented to cannabis
industry businesses, individuals and organizations, in both medical
and recreational sectors as well as ancillary industries. Awards go
to those deserving of historical recognition and esteemed
accolades.
"To win this award, just 94 days after the launch of the Test
Kit products, is truly an honor", said CEO of FutureWorld, Sam
Talari. "This award further demonstrates that we are not just
a technology and solutions company to the cannabis industry, but we
are truly innovators in the space. We constantly strive to discover
disruptive products in our sector, and this peer recognition is
confirmation of our efforts."
CB Scientific's PersonalAnalytics are the first tests for
consumers that are available for personal use to test for
cannabinoids, including THC and CBD, outside of a lab setting.
These affordable and high-quality tests provide results in ten
minutes or less, and have numerous uses for recreational and
medical purposes, including patients who need to use medical
cannabis and hemp-related products such as CBD oil.
Both THC and CBD home testing kits are available at several
outlets in Alaska, Michigan, California, Washington and Colorado,
specifically head shops, dispensaries and grow stores. The kits are
also available for purchase worldwide online at
www.cbscientific.com. The tests have been featured on ABC, CBS,
Fox, The Adam Dunn Show, as well as in publications such as High
Times and Forbes Magazine.
About CB Scientific
CB Scientific (http://www.cbscientific.com) is a wholly owned
Florida company based in Denver Colorado. CB Scientific is
continuing to develop new technologies specifically for cannabis
analytics. Senior management team are some of the primary men
advancing gas chromatography testing in Colorado. CB Scientific
believes every product sold to patients as "Medical Quality" should
be inspected for health benefits, safety, consistency, purity,
potency and packaged properly for distribution.
Senior management team of CB Scientific have worked with many of
the cannabis industry leaders in Colorado and have also been
featured in cannabis industry publications including High Times
Magazine, many trade publications, on-air interviews and panel
discussions across the United States. CB Scientific's focus has
been the education and safety of consumers combined with innovation
to put power into the hands of the patients. Values that
FutureWorld is pleased to embrace while ever striving to raise the
bar of cannabis analytics even higher.
About FutureWorld Corp
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a
U.S. Diversified Holding Company formed to capitalize on the
burgeoning Cannabis markets globally. FutureWorld, together with
its subsidiaries, focuses on the identification, acquisition,
development, and commercialization of cannabis related products,
such as industrial Hemp. FutureWorld, through its subsidiaries such
as HempTech and CB Scientific, provides personal and professional
THC and CBD test kits, pure CBD oil solutions, smart sensor
technology, communication network, surveillance security, data
analysis for smart cultivation and consultation for the industrial
hemp and legal medicinal cannabis. Our wireless agricultural smart
sensor networks offer precision to the agriculture, irrigation
systems, and greenhouses for the global cannabis and hemp industry.
FutureWorld and its subsidiaries do not grow, distribute or sell
marijuana.
To request further information about FutureWorld, please email
us at investors@futureworldcorp.com, log onto our website at
http://www.futureworldcorp.com or visit us at our Facebook page
https://www.facebook.com/futureworldenergy or on Twitter
#futureworldinc.
Forward-Looking Statements
This press release may contain forward-looking statements
covered within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements relate to,
among other things, plans and timing for the introduction or
enhancement of our services and products, statements about future
market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release
that are not historical fact and involve risks and uncertainties.
Our expectations regarding future revenues depend upon our ability
to develop and supply products and services that we may not produce
today and that meet defined specifications. When used in this press
release, the words "plan," "expect," "believe," and similar
expressions generally identify forward-looking statements. These
statements reflect our current expectations. They are subject to a
number of risks and uncertainties, including, but not limited to,
changes in technology and changes in pervasive markets. This
release includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that
are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for
anticipated actions.
CONTACT: Media Contact
FutureWorld Corp.
Http://www.futureworldcorp.com
Investor Relations
info@futureworldcorp.com
cox@futureworldcorp.com
(727) 474-1816 ext. 103
